For some years, in many British clinics, the treatment of choice for nongonococcal urethritis has been oxytetracyline, the dosage most frequently employed being 250 mg. four times a day for 5 days. The object of this investigation was to assess the value of larger or more prolonged dosage.
Prolonged oxytetracycline therapy in nongonococcal urethritis 267 diagnosed in a further two cases but none occurred in the 3rd month. Accordingly, the initial cure rate was 57 per cent. and the final cure rate 55 per cent. In Group B, 191 of 200 patients followed (95 per cent.) were judged to be cured at 1 month. In the succeeding 2nd and 3rd months there were ten and six recurrences respectively, giving cure rates at the 2nd and 3rd months of 90 and 87 per cent.
In Group C, 151 of 169 patients followed (89 per cent.) were considered to be cured after one month. Cure rates at the end of the 2nd and 3rd months were 82 and 72 per cent. respectively.
Discussion
The efficacy of the tetracyclines in the treatment of non-gonococcal urethritis has been under fairly frequent scrutiny for nearly 20 years and at the very least thirty published trials have contributed to the 'common knowledge' that cure will result in about 70 to 80 per cent. of cases treated with a 5-or 7-day course given in a dosage of 250 mg. every 6 hours. Nevertheless this 'common knowledge' is an assumption which conceals wide variations in reported cure rates deriving from trials of greatly different method and validity. Certainly the effect of tetracycline is genuine: this was best proved by Holmes, Johnson, and Floyd (1967) , who compared two tetracycline regimes with a placebo in a cross-over trial which involved patients under close scrutiny in an aircraft carrier with whom the problem of relapse versus re-infection was as near as possible eliminated. But of course of considerable importance in judging results is the time of the principal assessment for cure. Not only does the problem of re-infection increase with time, but so also does the spontaneous cure rate. It has been shown that early 'cure' can be obtained in about 20 to 25 per cent. of cases using no treatment or a placebo (Doyle, Gill, and Laird, 1957; Csonka, 1959) , but late cure may result in up to 70 per cent. of placebo-treated cases observed for between 1 and 3 months (Holmes and others, 1967 Considering patients receiving the 21-day course of tetracycline (Group B), it might have been argued that the superior early cure rate of 95 5 per cent. at one month was due to early assessment after the completion of treatment and to the effect of continued therapy protecting against early re-infection.
If the latter were the case, it seems to be a valid use of treatment, but the cure rate at 3 months (87-5 per cent.), whatever the modifying factors, was superior to that of the 5-day course (55 per cent.).
The effect of the 10-day course of 500 mg. four times a day (Group C) was clearly superior to that of the 5-day course (Group A). Side-effects in those taking the longer courses of treatment (mainly loose motions) were of rare occurrence.
In conclusion, it appears that the treatment of nongonococcal urethritis with oxytetracycline at a dose of 250 mg. given 6-hourly for 21 days is to be recommended. 
Summary

